Category: Smith & NephewSyndicate content

Royal Oak claims 'repless' generic sales model saves $100k a year

February 27, 2015 by Brad Perriello

Royal Oak Medical Devices touts its 'repless' generic sales model, saying it can save its hospital customers more than $100,000 a year on their orthopedic implant spends.

Royal Oak claims 'repless' sales model saves $100k a year

Royal Oak Medical Devices says it can save its hospital customers more than $100,000 a year on their orthopedic implant spends, using its so-called 'repless' generic sales model.

SNN invests in Michelson's Series B | Medtech funding for the week of February 16, 2015

February 20, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Smith & Nephew gets in on Michelson Diagnostics Series B round; Diabetes: Valeritas registers $90m IPO; HeartFlow raises $36m for non-invasive FFR system; Bellerophon prices $60m IPO low, issues more shares; Rainbow Medical raises $25m for China ops

Smith & Nephew gets in on Michelson Diagnostics Series B round

February 16, 2015 by Brad Perriello

Smith & Nephew gets in on Michelson Diagnostics Series B round

February 16, 2015 by Brad Perriello

Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.

Smith & Nephew gets in on Michelson Diagnostics Series B round

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Smith & Nephew CEO Bohoun: No-frills Syncera program a growth driver

February 5, 2015 by Brian Johnson

Smith & Nephew CEO Olivier Bohoun calls the 'no-frills' Syncera program, which replaces sales reps with an automated system, a growth driver but refuses to set expectations.

Smith & Nephew CEO Bohoun: No-frills Syncera program a growth driver

U.K. warns on Smith & Nephew's Renasys wound care device

January 26, 2015 by Brad Perriello

Regulators in the U.K. issue a medical device alert on Smith & Nephew's Renasys negative-pressure wound therapy device, following a field safety notice the company issued last October.

U.K. warns on Smith & Nephew's Renasys wound care device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Mako's Q4 turnaround has Stryker feeling confident

January 15, 2015 by Brian Johnson

With 20 placements of Mako's surgical robots in the final quarter of 2014, Stryker CEO Kevin Lobo is confident in the $1.7 billion acquisition – and in Stryker's ability to integrate future acquisitions.

Mako's Q4 turnaround has Stryker feeling confident

Stryker (NYSE:SYK) posted a stellar quarter of sales for the robotic surgical system it acquired in its $1.7 billion deal for Mako Surgical.

Stryker CEO Lobo skeptical on 'repless' generic sales models

January 14, 2015 by Brian Johnson

Stryker CEO Kevin Lobo says he doesn't view the so-called 'repless' generic sales models piloted by orthopedic rivals Smith & Nephew and Wright Medical as a serious threat.

Stryker CEO Lobo skeptical on 'repless' generic sales models

Get the complete picture with a MassDevice Plus membership. Registered users can login here.